Advances in Hidradenitis Suppurativa

Multimedia Medical Education

Supported by an educational grant from AbbVie.*
Medical accuracy confirmed at release date.

Recent Advances in Our Understanding and Management of HS: From Mild to Worsening HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Combined Medical and Surgical Approaches in Moderate-to-Severe HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Troubling Cases of HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Ask the Faculty
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Modifying the Impact of HS: Lifestyle Considerations
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Thrasyvoulos Tzellos, MD, MSc, PhD
Release Date: 15 October 2018
Addressing the Psychosocial Symptoms of HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018
Easing the Pain: Approaches for Clinicians Managing HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Falk G. Bechara, MD
Release Date: 15 October 2018
What’s the Goal? Perspectives on What We Want to Achieve for Patients With HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018

Faculty Communications

Case Studies, Literature Reviews, and Survey Results

Highlights from the 6th EHSF Conference in 2017
Kelsey R. van Straalen, MD
Hessel H van der Zee, MD

Join the Discussion
Survey Report: How Do Clinicians Approach the Management of Hidradenitis Suppurativa?
Caitriona Ryan, MD

Join the Discussion
Literature Review: Evaluating the Psychological Burden of HS and Its Impact on Relationships and Sexual Function
Hessel H van der Zee, MD, PhD

Join the Discussion

Patient Case Studies

50-year-old male patient with MS and severe chronic plaque psoriasis who presented to Hospital Virgen de la Victoria, Málaga,...

34-year-old male and a 40-year-old female, who developed aphthous ulcers on the oral mucosa and oral and vulvar mucosa, respectively,...

47-year-old male, diagnosed with psoriasis in 1995. He had received various treatments for 25 years, but the psoriatic condition...

See more >>

In the News

Increased Mortality After MI in Young Adults With Systemic Inflammatory Disease
Myocardial infarctions (MI) in young adults are twice as likely to be fatal in those with inflammatory conditions like psoriasis, lupus, or rheumatoid arthritis, according to results from a study published in the European Journal of Preventive Cardiology. “This suggests that the worse long-term...
AAD Releases First-Ever Guidelines for Treating Paediatric Patients With Psoriasis
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released guidelines to help ensure that paediatric psoriasis patients receive the best possible treatment and care. The joint AAD/NPF guidelines, published in the Journal of the American Academy of...
Psoriasis Appears Associated With Increased Risk of Developing, Dying of Cancer
Patients with psoriasis appear to have an increased risk of cancer incidence and cancer-related mortality, according to a study published in JAMA Dermatology. For the study, Alex Trafford, University of Manchester, Manchester, United Kingdom, and colleagues searched through 6 electronic databases...
See more >>

Conference Reports

Low Risk of Infections in Patients With Psoriasis Treated With Guselkumab for Up to 5 Years

By Denise Baez

VIRTUAL -- October 2, 2021 -- In patients with psoriasis treated with guselkumab for up to 5 years, serious infections and infection-related treatment-emergent adverse events (TEAEs) of special interest were infrequent, according to a study presented at the Virtual 30th...

TNFi Treatment Associated With a Decreased Risk of COVID-19-Associated Hospitalisation in Patients With Psoriasis

By Denise Baez

VIRTUAL -- October 1, 2021 -- Tumour necrosis factor inhibitor (TNFi) treatment during the coronavirus disease 2019 (COVID-19) pandemic was associated with a decreased risk of COVID-19 hospitalisation, compared with treatment with methotrexate or ustekinumab, according to a...

Once-Daily Roflumilast Foam Improves Severity, Burden of Itch in Patients With Scalp and Body Psoriasis

By Denise Baez

VIRTUAL -- September 30, 2021 -- Daily treatment with roflumilast 0.3% foam significantly improved measurements of itch in patients with scalp and body psoriasis, according to a study presented at the Virtual 30th European Academy of Dermatology and Venereology (EADV)...

see more >>

Recently Published

Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial
Kristina M Harris, Dawn E Smilek, Margie Byron, Noha Lim, William T Barry, James McNamara, Sandra Garcet, Robert J Konrad, Martin Stengelin, Pradeepthi Bathala, Neil J Korman, Steven R Feldman, Erin E Boh, Kirk Barber, Anne E Laumann, Yolanda Rosi Helfrich, Gerald G Krueger, Howard Sofen, Robert Bissonnette, James G Krueger
Infliximab-induced interstitial lung disease
Theodoros Karampitsakos, Ourania Papaioannou, Fotios Sampsonas, Argyrios Tzouvelekis
Association of Spondyloarthritis and sarcoidosis: a retrospective observational population-based matched cohort study
Ramón Mazzucchelli, Raquel Almodovar, Elisa Dieguez-Costa, Natalia Crespí Villarías, Elia Pérez Fernandez, Alberto García Vadillo
See more >>

Full-Text Articles

Acta Dermato-Venereologica
Impact of Etanercept on Vitamin D Status and Vitamin D-binding Protein in Bio-naïve Patients with Psoriasis
Maria Siekkeri Vandikas, Kerstin Landin-Wilhelmsen, Sam Polesie, Martin Gillstedt, Amra Osmancevic
Acta Dermato-Venereologica
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
Christopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, Christoffer V Nissen, Tomas Norman Dam, Kawa Khaled Ajgeiy, Alexander Egeberg, Lone Skov
Scientific Reports
Handheld versus mounted laser speckle contrast perfusion imaging demonstrated in psoriasis lesions
Ata Chizari, Mirjam J Schaap, Tom Knop, Yoeri E Boink, Marieke M B Seyger, Wiendelt Steenbergen
See more >>

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.